TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma.

Lakshmi Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.